| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 10 | |
| #2 | Canada | 8 | |
| #3 | United States | 8 | |
| #4 | WIPO (World Intellectual Property Organization) | 8 | |
| #5 | United Kingdom | 7 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Valia Kirti | 12 |
| #2 | Banks Stan Lee | 10 |
| #3 | Stinchcomb Audra Lynn | 10 |
| #4 | Golinski Miroslaw Jerzy | 10 |
| #5 | Eldridge Josh | 8 |
| #6 | Hammell Dana Carmel | 8 |
| #7 | Green Darren | 4 |
| #8 | Evans Charles Rodney Greenaway | 4 |
| #9 | Green Darren M | 4 |
| #10 | Brown Marc Barry | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB201600918D0 | Transdermal patch | |
| GB201600920D0 | Transdermal patch | |
| GB201600919D0 | Transdermal patch | |
| GB201520647D0 | Transdermal patches | |
| EP3169317A1 | Oxymorphone transdermal patch | |
| GB201402448D0 | Novel formulation | |
| GB201317717D0 | Novel formulation | |
| GB201317718D0 | Novel formulation | |
| EP3064199A1 | Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists |